This suggests a crucial dependence on PDGFR signalling and we show that TKIs overcome the DEXA mediated pro-proliferative and radio-protective activities, and that furthermore DEXA sensitises GBM cells and GSCs to sunitinib. The gene discussed is PDGFRB; the disease is glioblastoma.